NexMed expands San Diego facilities to accommodate pre-clinical research services

NexMed, Inc. (Nasdaq: NEXM), a specialty CRO and a developer of products based on the NexACT^® technology, today announced that it has expanded its San Diego facilities to accommodate an increase in demand for its pre-clinical research services. Bio-Quant now has approximately 28,000 sq. ft of modern, state-of-the-art laboratory, vivarium and office space.

Dr. Bassam Damaj, President and Chief Executive Officer of NexMed, stated, "Our Bio-Quant business has experienced continuous growth during the past five years, including an increase of over 20% in revenues in 2009, alone. This has been achieved, in part, through a prior diversification of our service capabilities and entrance into new geographical markets. The ongoing expansion of our facilities is in response to the rising demand for the specialized services that we offer."

SOURCE NexMed, Inc.